Epigallocatechin-3-gallate ameliorates hepatic damages by relieve fgf21 resistance and promotion of fgf21-ampk pathway in mice fed a high fat diet

HIGHLIGHTS

• who: Yuanyuan Zhang from the AnimalsExperimental protocols were approved by the Animal Care and Use Committee of Beijing Luhe Hospital, Capital Medical University and conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals. All efforts were made to minimize suffering of experimental mice in this research. Animal studies are reported in compliance with the ARRIVE have published the article: Epigallocatechin-3-gallate ameliorates hepatic damages by relieve FGF21 resistance and promotion of FGF21-AMPK pathway in mice fed a high fat diet, in the Journal: (JOURNAL)
• what: This study . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.